Merck Withdraws Lawsuit against Krka
Novo mesto, 29 June - US pharmaceutical company Merck has recently withdrawn a lawsuit against Slovenian drug maker Krka for patent infringement in the case of the cholesterol lowering agent Lovastatin. The lawsuit in which Merck made a claim of US$ 34 million was filed in 1996.
The rest of this news item is available to subscribers.
The news item consists of 635 characters (without spaces) or 130 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.